You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Osteoporosis

The PMC reviewed relevant performance measures and makes the following recommendations.

November 2018 printable version of recommendations.

ACP supports this measure.

ID# MIPS: TBD

More Information

Appropriate Use of DXA Scans in Women Under 65 Years Who do not Meet the Risk Factor Profile for Osteoporosis

Percentage of female patients aged 50 to 64 without select risk factors for osteoporotic fracture who received an order for a dual-energy x-ray absorptiometry (DXA) scan during the measurement period.
Date Reviewed: November 4, 2018

ACP does not support this measure.

ID# MIPS: 024
NQF: 0045
(NLE)

More Information

Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older

Percentage of adults 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the patient was or should be considered for osteoporosis treatment or testing. This measure is reported by the physician who treats the fracture and who therefore is held accountable for the communication.
Date Reviewed: November 4, 2018

ACP supports this measure.

ID# QPP/MIPS: 039
NQF: 0046

More Information

Screening for Osteoporosis for Women 65-85 Years of Age

Percentage of female patients aged 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosis.
Date Reviewed: November 19, 2017

ACP supports this measure.

ID# QPP/MIPS: 418
NQF: 0053

More Information

Osteoporosis Management in Women who had a Fracture

The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis in the six months after the fracture.
Date Reviewed: November 19, 2017